1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Dermatology Partnering 2010-2016: Deal trends, players and financials

The Global Dermatology Partnering 2010-2016: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Dermatology partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Dermatology partnering agreement structure
Dermatology partnering contract documents
Top Dermatology deals by value
Most active Dermatology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of dermatology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dermatology dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading dermatology deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active dermatology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to dermatology deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dermatology partnering deals by specific dermatology target announced since 2010. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.


Report scope

Global Dermatology Partnering 2010-2016 is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.

Global Dermatology Partnering 2010-2016 includes:

Trends in dermatology dealmaking in the biopharma industry since 2010
Analysis of dermatology deal structure
Access to headline, upfront, milestone and royalty data
Access to over 700 dermatology deal records
The leading dermatology deals by value since 2010


The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.

In Global Dermatology Partnering 2010-2016, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Dermatology Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 650 dermatology deals.
Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Table Of Contents

Global Dermatology Partnering 2010-2016: Deal trends, players and financials
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Dermatology dealmaking

2.1. Introduction
2.2. Dermatology partnering over the years
2.3. Dermatology partnering by deal type
2.4. Dermatology partnering by industry sector
2.5. Dermatology partnering by stage of development
2.6. Dermatology partnering by technology type
2.7. Dermatology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Dermatology partnering

3.1. Introduction
3.2. Disclosed financials terms for Dermatology partnering
3.3. Dermatology partnering headline values
3.4. Dermatology deal upfront payments
3.5. Dermatology deal milestone payments
3.6. Dermatology royalty rates

Chapter 4 - Leading Dermatology deals and dealmakers

4.1. Introduction
4.2. Most active in Dermatology partnering
4.3. List of most active dealmakers in Dermatology
4.4. Top Dermatology deals by value

Chapter 5 - Dermatology contract document directory

5.1. Introduction
5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Dermatology therapeutic target

Appendices

Appendix 1 - Directory of Dermatology deals by company A-Z 2010 to 2016
Appendix 2 - Directory of Dermatology deals by deal type 2010 to 2016
Appendix 3 - Directory of Dermatology deals by stage of development 2010 to 2016
Appendix 4 - Directory of Dermatology deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering


Table of figures

Figure 1: Dermatology partnering since 2010
Figure 2: Dermatology partnering by deal type since 2010
Figure 3: Dermatology partnering by industry sector since 2010
Figure 4: Dermatology partnering by stage of development since 2010
Figure 5: Dermatology partnering by technology type since 2010
Figure 6: Dermatology partnering by indication since 2010
Figure 7: Dermatology deals with a headline value
Figure 8: Dermatology deals with upfront payment values
Figure 9: Dermatology deals with milestone payment
Figure 10: Dermatology deals with royalty rates
Figure 11: Active Dermatology dealmaking activity- 2010 to 2016
Figure 12: Top Dermatology deals by value since 2010

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Dermatology Diagnostic Devices Market 2016-2020

Global Dermatology Diagnostic Devices Market 2016-2020

  • $ 2500
  • Industry report
  • September 2016
  • by Infiniti Research Limited

About Dermatology Diagnostic Devices Market The global dermatology diagnostic devices market is dominated by microscopes with a market share of 34% owing to its convenience in use. They are used in almost ...

Global Dermatology Devices Market Research Report 2016

Global Dermatology Devices Market Research Report 2016

  • $ 2508
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Dermatology Devices Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Dermatology Devices industry, focusing on the main ...

Generic Solid Dosage Forms: Products, Markets, Players and Outlook

Generic Solid Dosage Forms: Products, Markets, Players and Outlook

  • $ 3850
  • Industry report
  • November 2016
  • by Greystone Research Associates

Tracking a Moving Target The generic solid dosage form drug segment is a rapidly evolving and highly unpredictable environment that has been a challenge to decision makers attempting to map strategies ...

Global Telemedicine Market

October 2016 $ 4250

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.